argenx NV ADR (ARGX) — the peer cohort
As of 2026-11-02 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.
argenx NV ADR ranks 5 of 7 in its cohort on the Closelooknet composite (63/100) — the cohort is led by Halozyme Therapeutics Inc at 73/100.
| Name | Composite | Momentum | Quality | Valuation | Signal | Off 52w high |
|---|---|---|---|---|---|---|
| ARGX argenx NV ADR | 63 | 68 | 74 | 29 | info | 18.4% |
| HALO Halozyme Therapeutics Inc | 73 | 97 | 94 | 38 | ok | 3.8% |
| ARGX.BR Argen-X | 64 | 74 | 75 | 29 | info | 15.2% |
| ONC BeiGene, Ltd. | 64 | 83 | 64 | 30 | info | 7% |
| UCB.BR UCB SA | 64 | 72 | 71 | 44 | info | 3.5% |
| REGN Regeneron Pharmaceuticals Inc | 62 | 88 | 71 | 48 | bull | 0.8% |
| RIGL Rigel Pharmaceuticals Inc | 62 | 96 | 90 | 72 | ok | 3.9% |
Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.
FAQ · from the current data · as of 2026-11-02
Quick answers
Who are argenx NV ADR's peers in the Closelooknet universe?
The cohort is drawn from shared Closelooknet index membership first, then sector: Halozyme Therapeutics Inc (HALO), Argen-X (ARGX.BR), BeiGene, Ltd. (ONC), UCB SA (UCB.BR), Regeneron Pharmaceuticals Inc (REGN), Rigel Pharmaceuticals Inc (RIGL), as of 2026-11-02.
How does ARGX score against its peers?
argenx NV ADR's composite reads 63/100, ranking 5 of 7 in its cohort as of 2026-11-02; the cohort's highest composite is Halozyme Therapeutics Inc at 73/100. Closelooknet scores are research diary readings, not ratings or advice.
Mentioned on Closelooknet
Where ARGX appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000
Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- REGN Regeneron Pharmaceuticals Incindustry
- RIGL Rigel Pharmaceuticals Incindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- EXEL Exelixis Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- VRDN Viridian Therapeutics Incindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- BHVN Biohaven Ltd.industry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- KYMR Kymera Therapeutics Incindustry
- SEPN Septerna, Inc. Common Stockindustry
- ADMA ADMA Biologics Incindustry
- IRON Disc Medicine Inc.industry